Prolonged DAPT after acute coronary syndrome: individualise! - Panel

3 March 2019 (16:31 - 16:32)

Organised by:

4 More presentations in this session

Presentation thumbnail

This programme is supported by AstraZeneca in the form of an educational grant. The scientific programme has not been influenced in any way by its sponsor.

Presentation thumbnail

Case 1: A patient with a low DAPT score and an interventionist with a gut feeling.

Doctor A. Mischie (Montlucon, FR)

Presentation thumbnail

Case 2: The dilemma: a patient with both a high bleeding and thrombotic risk.

Doctor N. Morici (Milan, IT)

Presentation thumbnail

State of the Art lecture: Prolonged DAPT – when, in whom, how long?

Professor M. Valgimigli (Lugano, CH)

Access the full session

Session thumbnail

Prolonged DAPT after acute coronary syndrome: individualise!

The Event

Acute Cardiovascular Care 2019

3 March 2019 16:31 CET

You may be interested in

Congress Presentation

Optimizing antiplatelet therapy in ACS: a network meta-analysis of simplified regimens

1 September 2025

Congress Presentation

When should we prolong DAPT beyond 12 months?

1 September 2024

Congress Presentation

PRECISE-DAPT score for long-term bleeding prediction after acute coronary syndrome in patients managed without percutaneous coronary intervention

30 June 2021

Congress Session

Dual antiplatelet therapy titration after percutaneous coronary intervention: when to escalate, de-escalate, withdraw, and more

28 August 2023

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources